Alonzo Weems
Executive Vice President, Enterprise Risk Management, and Chief Ethics and Compliance Officer, Eli Lilly and Company
Alonzo Weems (he/him/his) is executive vice president, enterprise risk management and chief ethics and compliance officer of Eli Lilly and Company. He leads Lilly’s global ethics and compliance function.
Since joining Lilly as an attorney in 1997, Alonzo has held a variety of roles providing strategic legal counsel across different areas of the business ranging from oncology clinical development and global health outcomes to commercialization of products in multiple therapeutic areas. His prior leadership roles include vice president and deputy general counsel for corporate legal functions, general counsel for Lilly USA and general counsel for biomedicines and diabetes. In his role as general counsel for the global biomedicines and diabetes businesses, Alonzo led the legal teams in Australia, Canada, Europe, Japan and China, Lilly’s largest markets outside of the United States. Prior to becoming general counsel for Lilly USA, he served as general counsel and corporate secretary for Lilly Canada. From 2006-2008, Alonzo oversaw the refresh of the company’s workforce diversity and inclusion strategy in his role as director for global workforce diversity.
He earned a Bachelor of Arts degree from Wabash College and a J.D. from the Indiana University Maurer School of Law.
Alonzo serves on the board of visitors for the IU Maurer School of Law and the boards of directors for the International School of Indiana and Early Learning Indiana. He is a member of the Chief Ethics and Compliance Officer Steering Committee for the International Federation of Pharmaceutical Manufacturers & Associations, a past president and member of the Indiana Board of Law Examiners and a past member of the law section executive committee for the Pharmaceutical Research and Manufacturers of America.
